raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:760

Purine nucleoside phosphorylase deficiency

Synonyms: PNP deficiency · PNPase deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Childhood, Infancy
Status
active

A rare immune disease characterized by progressive immunodeficiency leading to recurrent and opportunistic infections, autoimmunity and malignancy as well as neurologic manifestations.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPurine nucleoside phosphorylase deficiencyPNP deficiency · PNPase deficiency
frDéficit en purine nucléoside phosphorylaseDéficit en PNP · Déficit en PNPase
dePurin-Nukleosid-Phosphorylase-MangelPNP-Mangel · PNPase-Mangel
esDeficiencia de purina nucleósido fosforilasaDeficiencia de PNP · Deficiencia de PNPasa
itDeficit di purina nucleoside fosforilasiDeficit di PNP · Deficit di PNPasi
nlDeficiëntie van purinenucleosidefosforylasePNP-deficiëntie · PNPase-deficiëntie
ptDeficiência de nucleosídeos purínicos fosforilase
plNiedobór fosforylazy nukleozydów purynowychNiedobór PNP · Niedobór PNPazy
csDeficit purin-nukleosid-fosforylázyDeficit PNP · Deficit PNPázy
ukДефіцит пуриннуклеозидфосфорилазиДефіцит PNP · Дефіцит PNPази
zh嘌呤核苷磷酸化酶缺陷嘌呤核苷磷酸化酶缺陷
trPürin nükleozid fosforilaz eksikliğiPNP eksikliği · PNPase eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM613179Evalidated
ICD-10D81.5Especificvalidated
ICD-114A01.1YNTBTindexvalidated
MONDO0013171Evalidated
MeSHC562587Evalidated
UMLSC0268125Evalidated
GARD4606Evalidated
MedDRA10086665Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PNPDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:7892ENSG0000019880516405014q11.2purine nucleoside phosphorylase11453975[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families72 casesWorldwideCase(s)Validated30885031[PMID]
Point prevalence<1 / 1 000 000—EuropeClass onlyValidatedORPHANET_30885031[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

29 annotations · validated 2019-11-05
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002843Abnormal T cell morphology
HP:0011935Decreased urinary urate
Frequent (79-30%)
HP:0000707Abnormality of the nervous system
HP:0001890Autoimmune hemolytic anemia
HP:0002960Autoimmunity
HP:0005363Humoral immunodeficiency
HP:0003537Hypouricemia
HP:0002719Recurrent infections
HP:0002205Recurrent respiratory infections
HP:0004430Severe combined immunodeficiency
HP:0032166Unusual gastrointestinal infection
Occasional (29-5%)
HP:0011442Abnormality of central motor function
HP:0001251Ataxia
HP:0000708Atypical behavior
HP:0100021Cerebral palsy
HP:0045080Decreased proportion of CD3-positive T cells
HP:0001263Global developmental delay
HP:0000752Hyperactivity
HP:0001276Hypertonia
HP:0001252Hypotonia
HP:0001249Intellectual disability
HP:0001888Lymphopenia
HP:0002664Neoplasm
HP:0002313Spastic paraparesis
HP:0001257Spasticity
Very rare (<4-1%)
HP:0001973Autoimmune thrombocytopenia
HP:0000407Sensorineural hearing impairment
HP:0001297Stroke
HP:0002725Systemic lupus erythematosus

Run the differential on the 2 obligate / very frequent terms

Annotation source: 1931007[PMID]_16176880[PMID]_22038677[PMID]_22132981[PMID]

7

Sources for this card